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Summary
Type II diabetes (T2D) affects over 10% of the US population and is a growing dis-
ease worldwide that manifests with numerous comorbidities and defects in
inflammation. This dysbiotic host response allows for infection of the host by
numerous microorganisms. In the course of T2D disease, individuals can develop
chronic infections including foot ulcers and periodontitis, which lead to further
complications and opportunistic infections in multiple body sites. In this study,
we investigated the serum of healthy subjects and patients with T2D with
(T2DP) or without periodontitis for both microbiome signatures in addition to
cytokine profiles. Surprisingly, we detected the presence of Acinetobacter bau-
manii in the serum of 23% individuals with T2D/T2DP tested. In T2DP, IL-1b,
TNF-a, MCP-1, IL-6, IL-8, and IFN-g were significantly elevated in ABC-positive
subjects. As an emerging pathogen, A. baumanii infection represents a risk for
impaired inflammation and the development of comorbidities in subjects with
T2D.
Introduction
Type-II diabetes (T2D) is a chronic inflammatory disease affecting 10.5% of the US population, with rising
prevalence both in the United States and worldwide (Whiting et al., 2011; National Diabetes Statistics
Report | Data & Statistics | Diabetes | CDC, 2020). Individuals with T2D typically have numerous comorbid-
ities and are at a greater risk of both opportunistic and nosocomial infections, which can result in significant
morbidity, including amputations, and lost quality of life (QOL) measures (Vardakas et al., 2007; Erben et al.,
2013; McDonald et al., 2014; Ferlita et al., 2019; Kim et al., 2019). Thus, care must be taken to prevent and
monitor the infection status of these individuals, as the development of diabetic mucosal and skin lesions
across the body can impact the host immune and diabetic responses. Key infection prevention includes
minimizing portals of entry and colonization by numerous pathogens. One example of such a portal of entry
is the emergence of diabetic foot ulcers, which can develop diabetic foot infections (DFIs). Roughly 15% of
adults with T2D develop foot ulcers and 14% of these subjects undergo amputation, with the remainder
needing extensive debridement, negative pressure treatments, and other therapies including antibiotics,
which result in prolonged hospitalization time, lengthy healing duration, and increased treatment costs
(Reiber et al., 1998; Driver et al., 2010).
In addition to DFIs, subjects with T2D are3 times more likely to develop periodontitis (Emrich et al., 1991;
Wu et al., 2020). Periodontitis is an inflammatory oral disease accompanied by a polymicrobial biofilm infec-
tion that can lead to tissue damage, chronic lesions, and tooth/bone loss in the oral cavity (Irfan et al., 2001;
Genco et al., 2020; Mann et al., 2020). During periodontal infection, the healthy oral microbiome, especially
in the subgingival space (along teeth below the gumline, including periodontal ligament, epithelium, alve-
olar bone, and connective tissues), transitions to one enriched with several opportunistic pathogens that
exacerbate inflammation and host tissue damage both locally and systemically (Socransky et al., 1998; Grif-
fen et al., 2012; Hajishengallis and Lamont, 2012; Roberts and Darveau, 2015; Nowicki et al., 2018; Curtis
et al., 2020). Although protective, acute inflammation is a helpful immune response, it is characterized
by rapid activation of inflammation and subsequent return to homeostasis (resolution). Unresolved inflam-
mation that fails to control the trigger leads to chronic lesions and is a hallmark of both periodontitis and
T2D.
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More acute bacteremia can manifest in diseases such as endocarditis or other distal infections by oral mi-
crobes (Lockhart and Durack, 1999; Parahitiyawa et al., 2009; Carrizales-Sepúlveda et al., 2018). Various
systemic diseases are in fact influenced by microbial metabolism and host interactions. ‘‘How’’ and
‘‘why’’ immune system imbalance fails to control microbial pathogenic transition remains an active area
of investigation. Increasing evidence implicates periodontal diseases, especially periodontitis in adults,
as a potential risk factor for increasedmorbidity and mortality from systemic conditions including diabetes,
cardiovascular diseases, adverse pregnancy outcomes, and others (Genco et al., 2020; Kleinstein et al.,
2020b). This is due to two plausible mechanisms: a direct pathway leading to migration of the bacteria
to distal organs and an indirect pathway leading to production of microbial metabolites and/or activating
inflammatory mediators that activate the immune system locally and systemically. This is likely made
possible as periodontitis presents as a chronic inflammatory condition of the tooth-supporting structures
occurring with oral microbiome dysbiosis and continuous inflammatory burden. Notably, oral microbes
have also been detected (Dowd et al., 2008; Gardner et al., 2013) and isolated from DFIs (Bowler and Da-
vies, 1999; Citron et al., 2007). Thus, we hypothesized that patients with T2D might be at a greater risk of
extraoral infection and may exhibit changes in microbiota that transiently occupy their bloodstream. We
further hypothesized that these changes would be even more apparent in patients with T2D with periodon-
titis (T2DP) and that these patients may carry potential DFI-colonizing oral species in their bloodstream.
Our initial investigations toward these hypotheses utilized samples derived from previous work on resolu-
tion of inflammation in T2D (Freire et al., 2017) and are reported here, with unexpected results.
To investigate the possibility of oral species presence in the bloodstream, we compared the serum micro-
biomes of subjects with T2D and T2DP versus a healthy cohort. Unexpectedly, we detected Acinetobacter
baumanii in 23% of the subjects with T2D/P in our study. A. baumanii is an emerging infectious pathogen
(Villar et al., 2014) notorious for its evolving antibiotic resistances (Gootz and Marra, 2008; Vázquez-López
et al., 2020) and nosocomial (Dijkshoorn et al., 2007; Ayoub Moubareck and Hammoudi Halat, 2020) and
bloodstream infections (Peleg et al., 2008) and is part of a cluster of Acinetobacter species with similar clin-
ical manifestations known as the AB or ABC complex (Gerner-Smidt and Tjernberg, 1993), which are highly
similar via ribotyping. ABC complex organisms present several particular risks to subjects with T2D, specif-
ically higher mortality rates for those with bacteremia (Leão et al., 2016) and for those with higher blood
glucose concentrations (Leung and Liu, 2019). Patients infected with A. baumanii after burns were 9.8 times
more likely to develop glucose intolerance, and 3 times more patients with T2D with burns developed
A. baumanii infections (27%) than patients without T2D (8.5%) (Furniss et al., 2005). Additionally,
A. baumanii has also been observed in DFIs, particularly alongside other multidrug-resistant pathogens,
presenting a grave concern for individuals with T2D (Castellanos et al., 2019; Henig et al., 2020). In addition
to DFIs, ABC complex organisms can also spread through the body and form infections in numerous organs
(Peleg et al., 2008; Al-Anazi and Al-Jasser, 2014). A. baumanii in a mouse pneumonia model led to
increased proinflammatory cytokines, reduced neutrophil infiltration into the lung, and increased extrap-
ulmonary dissemination (Qiu et al., 2009). In T2D, neutrophils present failure in early chemotaxis, but a hy-
per-inflammatory feedback loop emerges to compensate the initial myeloid cell failure (Kleinstein et al.,
2020a).
In this work, we first investigated whether or not we could detect signatures of oral bacteria; our findings
indicated minor, yet significant, microbiome compositional changes between healthy cohort and patients
with T2D and T2DP. We discovered that nearly one-fourth of the subjects with T2DP in our study contained
sequence reads identical to that of A. baumanii. The specific presence of A. baumanii was confirmed by
further clone library and 16S rDNA Sanger sequencing. In addition, we assayed the host response by cyto-
kine profiles of sera. When stratifying A. baumanii-positive T2D versus A. baumanii-negative T2D samples
we observed unique cytokine profiles, suggesting a specific microbial impact on systemic inflammation.
Although our methodology cannot indicate if A. baumanii was transiently present or a subclinical colonizer
of our T2DP cohort, we propose that these data reveal a much greater risk of currently ‘‘uninfected’’ indi-
viduals with T2D for A. baumanii exposure and infection than previously understood and should justify
more intensive and thorough investigation into AB complex colonization of patients with T2D.
Results
Patient demographics
Serum samples were generated from the population described in Table 1. A total of 81 subjects were inves-
tigated in this study, 57 with T2D, of which 29 had periodontitis (T2DP) as defined by the American
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Association of Diabetes (American Diabetes Association, 2015) and American Association of Periodontol-
ogy (AAP) (Armitage, 1999) criteria, respectively. All T2D donors were poorly controlled diabetic subjects
who had not taken antimicrobials, non-steroidal anti-inflammatory drugs, or insulin sensitizers within three
months. Diagnostic serum glucose measures were taken for all subjects, and HbA1C was measured for dia-
betic patients to stage disease status. As expected, poorly controlled diabetic subjects (HbA1c% >6.5%)
showed significantly elevated glucose levels (p < 0.0001; Table 1). There were no significant differences
in gender or ethnicity between healthy volunteers and diabetic patients. Diabetic patients showed
elevated body mass index and tended to be older than healthy controls (p < 0.05), consistent with known
disease biology. Periodontal condition was further stratified among the subjects according to the severity
of irreversible tissue loss (mild, moderate, severe) and reversible lesions called gingivitis according to AAP
(Armitage, 1999) criteria. Periodontal condition was significantly worse in diabetic compared with healthy







(N = 81) p value
Age (mean in years GSD) 46 G 10.72 55 G 10.78 52.78 G 11.40 <0.001
Gender (no., %)
Male 13 (54%) 29 (51%) 42 (51.85%)
Female 11 (46%) 28 (49%) 39 (48.15) 0.45
Ethnicity
Caucasian 15 (63%) 25 (43.86%) 40 (49.38%)
Hispanic 2 (8%) 7 (12.28%) 9 (11.11%)
African American 6 (25%) 23 (40.35%) 29 (35.80%)
Asian 0 2 (3.51%) 2 (2.47%)
Other 1 (4%) 0 1 (1.23%) 0.16
Smoking status (no., %)
Smokers 1 (4%) 5 (8.77%) 6 (7.41%)
Former smokers 0 21 (36.84%) 21 (25.93%)
Never smokers 23 (96%) 31 (54.39%) 54 (66.67%) 0.02
BMI (kg/m2; mean G SD) 29.34 G 2.60 32.93 G 6.02 31.87 G 5.48 <0.01
Blood cholesterol (mg/dL; mean G SD) 148.89 G 36.71 211.73 G 78.69 194.01 G 74.84 <0.001
HbA1c (%; mean G SD) – 7.48 G 1.61 – –
Blood Glucose (mg/dL; mean G SD) 99.25 G 19.29 190.84 G 60.58 163.70 G 66.69 <0.0001
Periodontal condition (no., %)
Healthy 24 (100%) 7 (12.28%) 31 (38.27%)
Mild 0 15 (26.32%) 15 (18.52%)
Moderate 0 11 (19.30%) 11 (13.58%)
Severe 0 12 (21.05%) 12 (14.81%)
Gingivitis 0 10 (17.54%) 10 (12.35%)
Stable periodontitis 0 2 (3.51%) 2 (2.47%) <0.0001
ABC positive (no., %)
Positive 0 13 (22.81%) 13 (16.05%)
Negative 19 (79%) 29 (50.88%) 48 (59.26%)
Not tested 5 (21%) 15 (26.32%) 20 (24.69%) 0.02
Neutrophil count (million cells, mean G SD) 74.82 G 58.56 158.22 G 90.08 131.90 G 94.51 <0.0001
Monocyte count (million cells, mean G SD) 63.79 G 50.35 113.91 G 60.09 99.22 G 63.28 <0.01
p values calculated by unpaired t tests or c2 (two-sided p values; italicized p < 0.05 significant).
BMI, body-mass index; ABC, A. baumanii;%, percentage; mg/dL, milligrams per deciliter; kg/m2, kilograms per square meter.
Smoking classification according to CDC National Health Interview Survey (NHIS).
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subjects (p < 0.0001). All healthy subjects had healthy periodontal condition compared with only 11% dia-
betic patients, with 15% diabetic subjects suffering from severe periodontitis. Current and former smokers
were near uniformly part of the T2D and T2DP groups with only one current smoker in the healthy group.
The entire study population had a median age range of 53G 11 years, and all subjects were outpatient and
thus not part of an extended hospital stay cohort.
Microbiome analysis controls for low template sequencing
Data generated here was part of a post hoc study of serum samples collected for a previous study (Freire
et al., 2017) and thus not available in the larger volumes ideal for 16S microbiome dataset generation. Low
template concentrations can produce microbiome signatures not derived from that in the biological sam-
ples due to amplification of contaminating genomic DNA (gDNA) in sterile buffers and reagents (Kennedy
et al., 2014; Salter et al., 2014; Kim et al., 2017), which often manifests as aquatic species signatures, many of
which are not compatible with growth in the human host (i.e., many do not even grow at 37C) (Kim et al.,
2017). A description of no-template/reagent-only control samples is provided in the Methods. Data within
this study are provided as either minimally filtered (mitochondrial, human, and chloroplast aligned reads
removed) or strict filtered (reads removed based on homology with reagent-only controls) and indicated
as such throughout the study. All sequence data are made available at NIH SRA Bioproject PRJNA664044,
and all scripts used for data generation, filtering, and analyses are provided in the Supplemental
Information.
We were able to generate abundant data from these samples with careful consideration paid to controls for
amplification bias and background bacterial gDNA contamination of commercial sterile reagents. First, we
utilized amplification of a mock standard library of 8 bacterial and 2 fungal species (Figures S1A and S1B) at
10 and 1 ng of total template, which indicated that our library preparation protocol was suitable for species-
level analysis where possible by V1-V3 sequence. Second, we utilized 13 separate no-template/reagent-
only controls, which were subjected to our sequence analysis pipeline, revealing frequently encountered
contaminating taxa. These taxa were filtered from each human-derived sample in the strict-filtered data-
sets only.
V1-V3 16S microbiome diversity analyses reveal minor but significant differences between
diabetic and nondiabetic groups
Serum and control samples were subject to bead beater lysis and gDNA purification. Purified gDNA was
amplified using the V1-V3-targeted 27F-519R primer pair (Stackebrandt and Goodfellow, 1991; Turner
et al., 1999). Quality trimmed reads were subjected to DADA2 analysis (Callahan et al., 2016) and aligned
to the SILVA database (Quast et al., 2013) to determine species-level identity where possible. Rarefaction
curve analysis was performed to ensure adequate sequencing depth (Figure S2), and resequencing of each
Illumina index was performed to generate greater sequencing depth without further template amplifica-
tion. Run-to-run variability between next-generation sequencing was found to be insignificant (Figure S3).
Data analysis and comparisons were performed via QIIME2 (Bolyen et al., 2019) as detailed in the Methods.
We first quantified alpha and beta diversity between the healthy, T2D, and T2DP subject groups for our
strict filtered (Figures 1and S7) and minimally filtered data (Figure S4). For both datasets, species richness
for T2D and T2DP groups were significantly different than the healthy cohort, which was also significantly
different when compared with T2DP in each dataset for species evenness (T2D more rich, T2DP less rich,
and less even). Beta diversity was significantly less for healthy subjects versus T2D and greater when
compared with T2DP for either minimal or strict filtered datasets. Thus, we observed minor but significant
shifts in microbiome composition between subject groups.
To begin investigating which taxa contributed to this composition difference we first looked at a phylum-
level display of our taxonomically assigned data (Figure 2). Figures 2A and 2B, respectively, indicate
phylum-level data for strict versus minimal filtered datasets. Similar trends in phyla distribution were
evident for either dataset and reveal minor phylum-level changes between subject groups.
MED and DADA2 analysis reveal the presence of Acinetobacter baumanii
Given our initial investigation into whether or not there were differences between T2D and T2DP micro-
biota and a preliminary hypothesis that oral taxa would be enriched in T2DP serum, we first used a minimal
entropy decomposition (MED) analysis identical to the one used previously to characterize oral
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microbiomes (Eren et al., 2014). Oligotyped ‘‘nodes’’ or representative sequences were aligned to both the
Human Oral Microbiome (HOMD) (Escapa et al., 2018) and Ribosomal Database Project (RDP) (Cole et al.,
2014) databases, and species were assigned based on 98% or higher sequence identity when comparing
nodes to reference databases. We next compared species-assigned data between subject groups by linear
discriminate analysis effect size measurements (LEfSe) (Segata et al., 2011). Using MED-analyzed data for
healthy versus all subjects with T2D (Figure 3) we detected significant enrichments of some oral species
(Streptococcus cristatus, Neisseria flavescens) and also some known reagent contaminants (Ralstonia pick-
etti, Afipia broomeae) alongside other soil and freshwater microbes that we suspect are also contaminants
(Flectobacillus, Stenotrophomonas, Sphingobium, Arthrobacter). Surprisingly, we observed A. baumanii
significantly enriched in the T2D population as a whole. For MED analysis, reads assigned as
A. baumanii were present from 0.01% to 7.3% of total reads in 8 and 5 subjects with T2D and T2DP, respec-
tively. No reads assigned to A. baumanii were detected in any healthy subject. DADA2 amplicon sequence
variants (ASVs) are similar to MED nodes, and we observed that one ASV node was a perfect match to the
singular MED node assigned to A. baumanii based on 100% RDP alignment across its full sequence.
In our DADA2/QIIME2-based analysis we performed taxonomical assignment for each DADA2 ASV node
aligned to either the Greenegenes (DeSantis et al., 2006) (not shown) or SILVA database version 132 (Quast
et al., 2013). Phylum-level taxonomic assignments of DADA2 data aligned to SILVA were used in Figure 2.
ASVs are similar to MED nodes, and we observed that one ASV node was a perfect match to the singular
MED node assigned to A. baumanii based on 100% RDP alignment across its full sequence. This ASV was
assigned only to the Acinetobacter genus despite a 100% full-length match to A. baumanii sequence at the
RDP database and the NCBI non-redundant database (not shown). Based on this, we manually assigned
this ASV to A. baumanii and found that reads now assigned to A. baumanii were present from 0.01% to
9.1% of total reads in 8 and 5 subjects with T2D and T2DP, respectively, with no reads assigned to
A. baumanii detected in any healthy subjects. This demonstrated agreement between both MED and
A
B C
Figure 1. 16S alpha and beta diversity of serum microbiomes changes with subject status
(A–C) Species richness is displayed based on Faith’s phylogenetic diversity (Faith, 1992) (A), and species evenness is
based on Pielou’s evenness index (Pielou, 1966) (B) for healthy, type-II diabetic patients (T2D), and type-II diabetic
patients with periodontitis (T2DP) samples. Significance was determined by Kruskal-Wallis analysis of variance (Kruskal
and Wallis, 1952) for each comparison indicated, and Benjamini-Hochberg correction (Benjamini and Hochberg, 1995)
was applied to generate adjusted q-values. All data used were strictly filtered based on no-template control indexes. *q-
value < 0.002 compared with healthy, **q-value < 0.0004 compared with healthy and with T2D. (C) Beta diversity Bray-
Curtis distances. Pairwise PERMANOVA of each category versus each (group size of 3, n = 112) was performed in 999
permutations. ***q-value differs from ‘‘healthy’’ < 0.001. See also Figure S4.
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DADA2-based 16S data analysis. LEfSe analysis was again performed on healthy subjects versus all with
T2D, as well as between all three subject groups, and demonstrated again that A. baumanii was signifi-
cantly elevated among all T2D samples (Figure S5).
We next looked at differences in microbiome compositions across subjects by plotting Bray-Curtis
distances via non-metric multidimensional scaling (NMDS) while distinguishing subject groups as well as
presence or absence of ABC bacteria (Figure 4). Broadly, T2D and T2DP samples had less overlap in
composition, whereas healthy samples intersected either group. ABC status did not seem to form a distinct
microbiome cluster, suggesting that there was no unique microbiota composition for ABC-positive sub-
jects apart from A. baumanii sequence detection.
Validating the presence of A. baumanii in subjects with T2D
The finding of ABC sequences was unexpected, as study participants were not hospitalized or under treat-
ment for any infection(s), and we wished to confirm this result by other techniques. This was especially
needed as the V1-V3 portion of the 16S rDNA sequence only differs between A. baumanii and Acineto-
bacter nosocomialis by one nucleotide substitution. Using PCR primers for the 16S rDNA region that en-
compasses nearly all differentiating 16S nucleotides between Acinetobacter species we generated ampli-
cons from a portion of our ABC-positive samples alongside negative healthy and no-template control
A
B
Figure 2. Phylum-level diversity changes between subject status
(A and B) DADA2-analyzed data were aligned to the SILVA database for taxonomical assignment via QIIME2 as described
in Methods. Data from both sequencing runs were collapsed to phylum-level taxa and displayed for (A) strict filtered and
(B) minimally filtered conditions. Asterisks on the top indicate run-run sample pairs that were positive for A. baumanii.
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samples (Figure 5). PCR products were ligated into a TA vector, and individual colonies were propagated
and subjected to Sanger sequencing of plasmid inserts. The 1242-bp sequences were then aligned to the
NCBI reference RNA sequence database (refseq_rna). Each sequence (12 clones across 5 samples) was
identical and matched the A. baumanii 16S sequence across its length. This result validated our initial
16S detection of putative A. baumanii.
Host cytokine responses to T2D and T2DP versus health
In addition to serum microbiota, we also quantified 20 different human cytokines in serum samples across
all 3 patient groups (Figure 6). Based on relative abundance profiles, we observed that proinflammatory
cytokines were significantly elevated in A. baumannii-positive samples highlighted in the box (ABC+).
MCP-1 and IL-1b, classic proinflammatory cytokines, were increased in diabetic patients. Intriguingly,
T2D ABC-negative subjects did not show increase of these markers. ABC+ subjects showed significantly
higher expression levels of cytokines IL-1b, IL-6, IL-8, MCP-1, and IFN- g when compared with ABC-nega-
tive groups (I and V, p < 0.01).
Host cytokine responses to specific microbiota
Based on the cytokine abundance data and earlier microbiome sequencing, we were able to determine if
any specific taxa were significantly correlated with cytokine presence or absence in subjects with T2D
(Figure 7). A. baumanii was significantly correlated with elevated amounts of IFN-a, IFN-g, IL-12p70, IL-8,
and TNF-a. ABC+ subjects presented cytokine correlations consistent with a profile of chronic inflamma-
tion. IL-8 is a chemokine that impacts neutrophil phenotype and function, and excessive amounts of this
cytokine lead to chronic activation of phagocytes (Moore and Kunkel, 2019). Excessive production of
TNF-a increases failure of resolution of inflammation on innate immune cells by controlling a resolution
receptor (Freire and Van Dyke, 2013). Here, TNF-a showed a significant increase in ABC+ subjects, suggest-
ing co-existence with ABC in the serum of patients with T2D. We also performed an identical analysis for
healthy subjects and saw several genera or species with significant correlations (Figure S6). In healthy sub-
jects unique profiles were found, correlated with lower levels of proinflammatory cytokines and co-clus-
tered with ABC-negative samples.
Although low template concentration microbiome profiling presents many challenges, we were able to uti-
lize numerous control steps to minimize the impact of contaminating taxa. We were also able to demon-
strate that there were significant differences between subject groups that include taxa of likely biological
origins, and also that specific cytokines significantly correlated with the presence of distinct taxa. Most sur-
prisingly, we were able to detect A. baumanii and confirm its presence in serum samples of patients with
Figure 3. Healthy subjects versus all subjects with T2D reveal a potential enrichment of A. baumanii
Initial minimal entropy decomposition (MED) analysis of 16S data with taxonomy assigned based on RDP database
alignment to generate species-level assignments was performed followed by linear discriminate analysis effect size
quantification (LEfSe). This revealed enrichment of several species/genera in subjects with T2D relative to healthy. DADA2
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T2D not known or currently diagnosed with any underlying infection. These data do not per se indicate
active infection but could also indicate colonization or transient exposure to A. baumanii for these subjects
compared with healthy subjects.
Discussion
Issues with amplification-based 16S studies from low template concentrations are well known (Sinha et al., 2015;
Kim et al., 2017; Pollock et al., 2018).We began this study as a post hoc analysis of existing serum samples from a
A
B
Figure 4. Beta diversity quantification between subject groups
(A and B) SILVA-assigned taxonomy of DADA2-analyzed 16S data was used to determine Bray-Curtis dissimilarity
between samples for strictly filtered (A) and minimally filtered (B) data. Non-metric multidimensional scaling and
statistical analysis for each subject group was performed in R using the vegan package as described in Methods. p-value
of 0.001 determined by PERMANOVA test via the adonis2 function.
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previous bank of anonymized specimens (Freire et al., 2017). As sample volumes of serum were mostly limited,
we relied on amplification of 16S rDNA, using V1-V3 region primers to improve the likelihood of identifying oral
taxa (Eren et al., 2014) that we hypothesized to exist in the diabetic with periodontitis part of our cohort. Tomini-
mize effects of amplification, we performed multiple high-throughput sequencing runs of amplified libraries to
increase sequence depth as opposed to further amplification and using a higher capacity sequencing platform.
Additionally, we also included numerous no-template controls throughout sample preparation and purification
to identify asmanyoutside contaminants as we could (Kennedy et al., 2014; Salter et al., 2014; Kimet al., 2017). As
a further control, we carried out amplification of mock community libraries (Figure S1) to determine if amplifica-
tion bias or infidelity affected taxonomic assignment. We also used two separate methods for correction of Illu-
mina-sequenced amplicon errors, DADA2 (Callahan et al., 2016) and minimal entropy decomposition/oligotyp-
ing (MED) (Eren et al., 2015), as well as comparing our data from multiple ribosomal databases for taxonomic
assignment (DeSantis et al., 2006; Quast et al., 2013; Cole et al., 2014). In addition to Illumina sequencing, we
performed a separate amplification of 16S rDNA followed by Sanger sequencing to independently confirm
the identity of putative A. baumanii sequence presence in a subset of our diabetic samples (Figure 5). Thus,
we have made great efforts to validate our findings as far as is feasible and have taken care not to overinterpret
data presented here.
We initially hypothesized that oral taxa would be enriched in the bloodstream of subjects with T2DP, and
potentially all subjects with T2D, compared with healthy subjects. Our microbiome data revealed changes
in composition between our three subject groups (Figures 1, 2, 3, 4, S4, and S5). However, there was only
enrichment of few oral taxa when healthy subjects were compared with all subjects with T2D and not with
subjects with T2DP alone, specifically S. cristatus andN. flavescens (Figure 3), which are not associated with
periodontitis. Their presence here could indicate further access to the bloodstream by oral microbes in the
T2D cohort, although this requires further verification. Given the limited template available for each sam-
ple, we cannot rule out that other oral taxa are not elevated in subjects with T2D/P, but more rigorous
testing of that hypothesis would require larger serum volumes and using a longitudinal approach. By far
the most surprising element of this dataset was the detection of A. baumanii- (Figures 3 and S5) assigned
reads unique to 13 subjects with T2DP and not present in any control or healthy subject samples.
A.baumanii represents a considerable risk to subjects with T2D includinghighermortality rates (Leão et al., 2016)
and a higher risk of infection in burn wounds, as well as DFIs (Furniss et al., 2005; Castellanos et al., 2019; Henig
et al., 2020). To confirm our V1-V3 amplicon data and to determine whether or not these were A. baumanii or
another ABC species, we used targeted near-full-length 16S rDNA primers that allowed us to sequence the ma-
jority of differentiating nucleotides necessary for ribotyping. Sequencing individual clones of these amplicons
Figure 5. Clone library design to verify ABC complex member identity
Amplification with oMR328-329 primers produced an amplicon between 120 and 1306 bp of the A. baumanii 16S rDNA
sequence. This allowed for Sanger sequencing of information-rich nucleotides indicated above allowing for species
differentiation beyond initial V1-V3 sequencing with the 27F-519R primers. The table beneath indicated the total number
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revealed 100%matches toA. baumanii, and no clones (n = 50) wereA. baumanii positive from indicated control
samples (Figure 5). This result was surprising, as none of the subjects in our T2D/P cohort were currently under
inpatient treatment or had any indication of underlying infection (apart from periodontitis). Given the method-
ology here, neither can we speculate on the true infection status of these individuals nor can we be certain if the
A. baumaniipresent were circulating in the bloodstream or were on the skin andmixed with the sample during a
blooddraw.Nomatter the route of entry,wewere able todetermine significant cytokine profile changes in T2DP
A. baumanii-positive subjects, as well as broader inflammatory changes in cytokine profiles between subjects
with T2DP and T2D and healthy subjects (Figure 6).
Cytokine dysregulation can impact the host locally and systemically, making the subject more prone to
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Figure 6. Cytokine profile quantification reveals distinct differences between subject groupings and A. baumanii
(ABC) presence
Heatmap showing immune mediator concentrations derived from serum of diabetic and healthy samples were compared
to understand the role of ABC in each sample group. (I) Diabetic/Healthy, (II) All ABC+/All ABC-, (III) ABC+Diabetic/ABC-
Diabetic, (IV) ABC+ Diabetic/Healthy, (V) ABC- Diabetic/Healthy. Data are clustered according to comparison groups
(red, highest expression; yellow, lowest expression). Hierarchical clustering was employed by Morpheus from the Broad
Institute (Morpheus, https://software.broadinstitute.org/morpheus). Observations from hierarchical clustering are shown
in a tree, with ABC groups highlighted in the box. ABC+ groups (II, III, and IV) showed significantly different (p < 0.01)
levels of IL-1b, IL-6, IL-8, MCP-1, IFN- g. *p value <0.01 between groups via unpaired Student’s t test (red, highest
expression; yellow, lowest expression).
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an increased metabolic burden, while often comorbid periodontal disease promotes microbial dysbiosis,
with both diseases resulting in a chronic state of inflammation. In the present study, A. baumanii was only
found in the serum of diabetic subjects, where an increase in proinflammatory cytokines was also
observed (Figures 6 and 7). We utilized an unbiased panel of 20 human cytokines to survey specific im-
mune responses to T2D and T2DP compared with those of healthy individuals. Although there are com-
plications presented by low template sizes in our samples, cytokine profiling from these same volumes
were well within desired assay volumes. As mediators of inflammation, cytokine production feeds forward
a cascade of signals that can impact tissue, organ, and overall host immunometabolism. In T2D, IL-1b,
TNF-a, MCP-1, IL-6, IL-8, and IFN-g were significantly elevated in ABC+ subjects and not in ABC-negative
subjects. Of these proinflammatory cytokines, IL-1b, TNF-a, and IL-8 suppression has been investigated
as therapeutic targets for clinical management of diabetes and associated chronic lesions (Peiró et al.,
2017; Feng et al., 2018). We previously observed increased TNF-a levels in cell cultured neutrophils
from subjects with T2D relative to cells derived from healthy subjects (Kleinstein et al., 2020a). Co-occur-
rence of bacteria in the serum and cytokines also differed among controls. In the current study, co-occur-
rence among cytokines was more evident in diabetic subjects (100 significant co-occurrences) versus
healthy individuals (30 significant co-occurrences) (Figures 7 and S6). A baumannii especially correlated
with neutrophil inflammatory signaling cytokine IL-8, which was not observed in healthy subjects. We
have previously shown differences in gene expression in neutrophils of individuals with T2D, which are
primed to mount an aberrant inflammatory response when compared with neutrophils of healthy individ-
uals (Kleinstein et al., 2020a), consistent with production of inflammatory cytokines observed here. In
contrast, IL-17a, P-selectin, and E-selectin levels were increased in diabetic subjects who were ABC-nega-
tive compared with ABC+ diabetic subjects. IL-4 and IL-10 did not co-occur with A. baumanii in any of the
healthy versus diabetic groups. The cytokine results provide an initial glimpse into the host response to
chronic inflammatory diseases, T2DP with and without the presence of A. baumannii, which may warrant
further investigation in larger studies.
In conclusion, this study has revealed modest serum microbiome compositional changes and signifi-
cant cytokine profile changes between subjects with T2D with or without periodontitis versus non-
T2D individuals, revealing an impaired host response when A. baumanii was present. We also present
here the potential for lurking A. baumanii colonization in asymptomatic subjects with T2D, possibly to
Figure 7. Host-microbial correlation-resolved type-II diabetic associations with inflammatory cytokines
HOMD/RDP assigned taxonomy of MED-analyzed 16S data for both T2D and T2DP samples and cytokine concentrations
were analyzed via Pearson correlation coefficient in R using the rcorr function. Significance was determined using the
asymptotic p values generated by rcorr with *p value <0.05, **p value <0.01. Data are strictly filtered with taxa present in
no-template controls subtracted. See also Figures S6, S8, and S9.
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a much larger extent than previously reported. In our opinion, these data present a strong justification
for further monitoring of individuals with T2D for A. baumanii colonization and support the need for a
more robust study to characterize the potentially greater spread of A. baumanii among individuals
with T2D.
Limitations of the study
Limitations of this study primarily include small template volumes available for serum samples in this post
hoc study. Blood and sera microbiome studies will always be more complex due to low bacterial tem-
plate concentrations inherent to these types of sample. Although we have made utmost efforts to vali-
date our main findings regarding A. baumanii presence, there are likely more interesting aspects to our
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Vázquez-López, R., Solano-Gálvez, S.G., Juárez
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Álvarez-Hernández, D.A., et al. (2020).
Acinetobacter baumannii resistance: a real
challenge for clinicians. Antibiotics (Basel) 9, 205.
Villar, M., Cano, M.E., Gato, E., Garnacho-
Montero, J., Miguel Cisneros, J., Ruı́z de Alegrı́a,
C., Fernández-Cuenca, F., Martı́nez-Martı́nez, L.,
Vila, J., Pascual, A., et al. (2014). Epidemiologic
and clinical impact of Acinetobacter baumannii
colonization and infection: a reappraisal.
Medicine 93, 202–210.
Whiting, D.R., Guariguata, L., Weil, C., and Shaw,
J. (2011). IDF diabetes atlas: global estimates of
the prevalence of diabetes for 2011 and 2030.
Diabetes Res. Clin. Pract. 94, 311–321.
Wu, C.-Z., Yuan, Y.H., Liu, H.H., Li, S.S., Zhang,
B.W., Chen, W., An, Z.J., Chen, S.Y., Wu, Y.Z.,
Han, B., et al. (2020). Epidemiologic relationship
between periodontitis and type 2 diabetes
mellitus. BMC Oral Health 20, 204.
ll
OPEN ACCESS





Impaired host response and the presence
of Acinetobacter baumannii in the serum
microbiome of type-II diabetic patients
Dasith Perera, Sarah E. Kleinstein, Benjamin Hanson, Hatice Hasturk, Ryan
Eveloff, Marcelo Freire, and Matthew Ramsey
Supplemental Information 1 
Supplemental Figures and Legends 2 
 3 
Figure S1. Mock library composition evaluation. Related to Figure 1. A Zymogen mock 4 
community library was used for sequence library construction at 10 and 1 ng in duplicate 5 
between both sequencing runs. QIIME2 / DADA2 unfiltered data was given taxonomical 6 
assignment via SILVA and assessed via the “q2-quality-control” plugin. (A) Taxon accuracy rate 7 
(TAR), taxon detection rate (TDR) and linear regression scores (r-squared) are plotted at each 8 
taxonomic level. (B) Expected vs observed abundance of each species in the mock community 9 
is plotted at each taxonomic level. (C)  Distance between false positive observations vs nearest 10 
expected feature. Misclassifications were unique to environmental contaminant taxa and no 11 
false negative features were observed (not shown).  12 
  13 
 14 
Figure S2. Alpha-diversity at different rarefaction levels. Related to Figure 1. Total observed 15 
OTUs (here ASVs) are plotted (A) vs sequencing depth and each sample that can 16 
accommodate that sequencing depth is plotted in (B).  17 
  18 
 19 
Figure S3. Run to Run variability quantification. Related to Figure 1. A Run vs Run Beta 20 
diversity comparison was performed for unfiltered data by comparing unweighted Unifrac 21 
distances as described in the methods. Pairwise PERMANOVA of Run-1 vs Run-2 (group size 22 
of 2, sample size of n=134 total indexes) was performed in 999 permutations resulting in a 23 
pseudo-F value of 0.567, p-value of 0.999 and corrected q-value of 0.999. No significant 24 
differences were observed between each run.  25 
  26 
 27 
Figure S4. 16S Alpha and Beta diversity of serum microbiomes changes with subject 28 
status. Related to Figure 1. Species richness is displayed based on Faith’s phylogenetic 29 
diversity (Faith, 1992) (A) and species evenness based on Pielou’s evenness index (Pielou, 30 
1966) (B) for healthy, type-II diabetic (T2D) and type-II diabetics with periodontitis (T2DP) 31 
samples. Each graph used minimally filtered data for analysis. Significance was determined by 32 
Kruskal-Wallis analysis of variance (Kruskal and Wallis, 1952) for each comparison indicated 33 
and Benjamini-Hochberg correction (Benjamini and Hochberg, 1995) was applied to generate 34 
adjusted q-values.  * indicates q-value < 2e-3 vs healthy, ** indicates q-value < 0.024 vs 35 
healthy, (C) Beta-diversity Bray Curtis distances. Pairwise PERMANOVA of each category vs 36 
each (group size of 3, n=112) was performed in 999 permutations. *** indicates q-value differs 37 
from healthy < 0.001. 38 
  39 
 40 
Figure S5. LEfSe Comparisons reveal taxonomical differences between subject groups. 41 
Related to Figure 3. (A) LEfSe Cladogram plots (Segata et al., 2011) reveal general taxonomic 42 
shifts compared to (B) specifically enriched genera or species in all diabetics vs healthy and (C) 43 
compared across all 3 subject groups. Data was generated from DADA2 / QIIME2 analyzed 44 
data aligned to the SILVA database that was then filtered for contaminating taxa abundant in 45 
no-template control indexes. Pseudomonas genus / species level results were also removed for 46 
clarity.  47 
  48 
 49 
Figure S6. Cytokine correlation with specific taxa in healthy subjects. Related to Figure 7. 50 
HOMD/RDP assigned taxonomy of MED analyzed 16S data for healthy samples and cytokine 51 
concentrations were analyzed via Pearson correlation coefficient in R using the rcorr function. 52 
Significance was determined using the asymptotic p-values generated by rcorr with * =  p-value 53 
<0.05 ** = p-value <0.01. Data are strictly filtered with taxa present in no-template controls 54 
subtracted.  55 
 56 
  57 
 58 
Figure S7. 16S Alpha and Beta diversity of serum microbiomes changes with subject 59 
status. Related to Figure 1. Alpha diversity is displayed based on Shannon’s index (Shannon 60 
and Weaver, 1975) (A) and species evenness based on Simpson’s evenness measure 61 
(Simpson, 1949) ) (B) for healthy, type-II diabetic (T2D) and type-II diabetics with periodontitis 62 
(T2DP) samples. Each graph used minimally filtered data for analysis. Significance was 63 
determined by Kruskal-Wallis analysis of variance (Kruskal and Wallis, 1952) for each 64 
comparison indicated and Benjamini-Hochberg correction (Benjamini and Hochberg, 1995) was 65 
applied to generate adjusted q-values.  * indicates q-value < 1e-5, ** indicates q-value < 0.007, 66 
(C) Beta-diversity unweighted Unifrac distances. Pairwise PERMANOVA of each category vs 67 
each (group size of 3, n=112) was performed in 999 permutations. *** indicates q-value differs 68 
from ‘healthy’ < 0.02. 69 
 70 
  71 
 72 
Figure S8. Host-microbial correlation resolved type-II diabetic associations with 73 
inflammatory cytokines. Related to Figure 7. SILVA assigned taxonomy of DADA2 analyzed 74 
16S data for both T2D and T2DP samples and cytokine concentrations were analyzed via 75 
Pearson correlation coefficient in R using the rcorr function. Significance was determined using 76 
the asymptotic p-values generated by rcorr with * =  p-value <0.05 ** = p-value <0.01. Data are 77 
strictly filtered with taxa present in no-template controls subtracted.  78 
 79 
Figure S9. Cytokine correlation with specific taxa in healthy subjects. Related to Figure 7. 80 
SILVA assigned taxonomy of DADA2 analyzed 16S data for healthy samples and cytokine 81 
concentrations were analyzed via Pearson correlation coefficient in R using the rcorr function. 82 
Significance was determined using the asymptotic p-values generated by rcorr with * =  p-value 83 
<0.05 ** = p-value <0.01. Data are strictly filtered with taxa present in no-template controls 84 
subtracted.  85 
  86 
Transparent Methods 87 
Subject recruitment, sampling and storage 88 
 89 
Subject recruitment has been described previously (Freire et al., 2017). Peripheral venous blood 90 
(∼60 ml) was collected from patients diagnosed with T2D and from healthy nondiabetic controls. 91 
Blood samples were collected and centrifuged at 2300 rpm, and serum was isolated and frozen 92 
at -80°C until analysis under IRB protocol #13-07. All subjects gave signed informed consent 93 
prior to study evaluations. Clinical periodontal data and peripheral venous blood were collected. 94 
The diagnosis of T2D was made by the subject’s primary care physician following American 95 
Association of Diabetes guidelines (American Diabetes Association, 2015). Information was 96 
collected on subject demographics (age, gender, self-reported ethnicity, and self-reported 97 
smoking status), body-mass index (BMI; kg/m2), blood total cholesterol, blood glucose (point-of-98 
care), percent hemoglobin A1C (HbA1c), and periodontal condition (Armitage, 1999). HbA1c 99 
was used to determine the level of glycemic control for diabetic subjects. One T2D individual 100 
lacked HbA1c measurements but fit based on all other diagnostic criteria (blood glucose >200 101 
mg/dl) as well as cytokine profiles in accord with other T2D individuals. Neutrophil and 102 
monocyte cell counts were determined by lab assay (described below). Individuals were 103 
excluded if they were taking insulin sensitizers, nonsteroidal anti-inflammatory drugs, or 104 
antimicrobials within 3 months of study initiation. Smoking status was defined by CDC NHIS 105 
terms 106 
(https://www.cdc.gov/nchs/nhis/tobacco/tobacco_glossary.htm#:~:text=Former%20smoker%3A107 
%20An%20adult%20who,in%20his%20or%20her%20lifetime). Site collection before blood 108 
draw: Samples were drawn in clinical phlebotomy settings. From all serum sampled for this 109 
microbiome study, a total of 81 subjects (N=24 healthy, N=57 T2D) were included for analysis, 110 
all of whom were unrelated and over 18 years of age (range: 28-79 years of age). 111 
 112 
Sample preparation for 16S analysis 113 
 114 
DNA Extraction 115 
 116 
Frozen serum from N=81 samples (N=24 healthy, N=32 T2D and N=25 T2DP) were thawed on 117 
ice and aliquots were separated for DNA extraction. DNA was extracted using the Epicentre 118 
MasterPure Complete DNA and RNA Purification kit (Lucigen, WI, USA). Extraction was carried 119 
out using the manufacturer’s instructions, with modifications that enabled bead beating. Briefly, 120 
200µL of Tissue and Cell Lysis Solution (2x), 100µL of nuclease free water and 2µL of 121 
Proteinase K were added to Lysing matrix B (LMB) tubes (MP Biomedicals, Santa Ana, CA). 122 
Thereafter 100µL of serum was added to the tubes and placed in a Beadbeater (Biospec) for 30 123 
seconds, then placed on ice for 3 minutes and then repeated. Each round of DNA extractions 124 
included a no template control, which consisted of 100µL nuclease free water instead of serum. 125 
The samples were then incubated and extracted as described in the manufacturer’s instructions. 126 
Total DNA was precipitated using the manufacturer’s instructions, however 300 µL of MPC 127 
Protein Precipitation Reagent was used to accommodate the increased volume. DNA was 128 
eluted in 50µL of nuclease free water. 129 
  130 
16s rDNA primers 27F 131 
(TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGAGAGTTTGATYMTGGCTCAG) and 519R 132 
(GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGWATTACCGCGGCKGCTG) 133 
(Stackebrandt and Goodfellow, 1991; Turner et al., 1999) were used to amplify the V1-V3 134 
regions of 16s rDNA in a 50 µL reaction using 2x Q5 HiFi mastermix (New England Biolabs, 135 
Ipswitch, MA) and 23 µL of extracted DNA (35 cycles). 136 
      137 
Illumina MiSeq Library preparation 138 
 139 
After the first round of PCR was carried out it was cleaned with Ampure XP beads (Beckman 140 
Coulter, Pasadena, CA) and then visualized by agarose gel electrophoresis. Full indices and 141 
adapters were added using the Illumina Nextera Index Kit (Illumina, San Diego, CA) by running 142 
the second round of PCR (50 ng of template DNA, 5 cycles) in 2x Phusion HF Master Mix (New 143 
England Biolabs, Ipswitch, MA). PCR were then cleaned with Ampure XP beads and analyzed 144 
by agarose gel electrophoresis and using the Agilent BioAnalyzer DNA1000 chip (Agilent 145 
Technologies, Santa Clara, CA). Samples were then quantified and normalized prior to pooling 146 
using a Qubit fluorimeter (Invitrogen, Carlsbad, CA). The final pooled library was quantified with 147 
the KAPA Biosystems Illumina Kit (KAPA Biosystems, Woburn, MA) via qPCR in a Roche 148 
LightCycler480. Samples were sequenced (2x250 bp paired-end) on an Illumina MiSeq 149 
(Illumina, San Diego, CA) at the Rhode Island Genomics and Sequencing Center (Kingston, RI). 150 
 151 
Mock Community Standards Preparation 152 
In order to quantify potential bias due to low template concentrations, PCR amplification, and 153 
contamination, we performed mock library assemblies with commercially available bacterial 154 
genomic DNA templates (Zymo Research #D6305).  We amplified 2 libraries using 10 and 1 ng 155 
total starting templates in both sequencing runs for a total of 4 mock libraries synthesized.Total 156 
DNA species composition is provided in the manufacturer’s instructions.  157 
16S clone library resequencing 158 
 159 
Primers were made to amplify regions of 16s rDNA that enable differentiation of the 160 
Acinetobacter species. Primers used were  161 
oMR328 (TAGCGGCGGACGGGTGAGTAATGCTTA) and 162 
oMR329 (TTCCGACTTCATGGAGTCGAGTTGCAGAC). 50 µL reactions in 2x Q5 mastermix 163 
(New England Biolabs, Ipswitch, MA) were run for 35 cycles using 23 µL of DNA extracted from 164 
serum as the template. The products were then purified using the Qiagen PCR purification kit 165 
according to the manufacturer’s instructions. Gotaq 2x mastermix (Promega, Madison, WI) was 166 
used to generate ‘A’ overhangs via PCR for 5 cycles using 10 µL of purified DNA as the 167 
template. 4µL of the resulting PCR products were then used to generate clones using the TOPO 168 
TA Cloning Kit (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions which 169 
was modified to use 0.5µL of TOPO vector. Clones were then transformed into NEB5α cells 170 
using the manufacturer’s instructions and plated on LB plates supplemented with 0.1mM IPTG 171 
and 40µg/mL Kanamycin. Additionally, 40µl of 40mg/mL of X-gal was spread onto each plate 172 
prior to plating to enable blue-white screening. The plates were incubated for 24 hours at 37°C. 173 
White colonies were inoculated into liquid cultures of LB supplemented with 40µg/mL 174 
kanamycin. Plasmids were extracted using QIAprep Spin Miniprep kit (Qiagen, Venlo, 175 
Netherlands). Inserts were sequenced using the M13 Forward (GTAAAACGACGGCCAGTG) 176 
and M13 Reverse (CACAGGAAACAGCTATGACC) primers on an Applied Biosystems 3500xl 177 
using the “BigDye” Terminator v3.1 Cycle sequencing kit. Sequences were analyzed using 178 
NCBI BLAST (NCBI Resource Coordinators, 2018). A maximum of 10 colonies were screened 179 
for each sample or until a sequence matched a species belonging to the Acinetobacter 180 
baumanii- calcoaceticus complex.  181 
 182 
 Cytokine Quantification 183 
 184 
Frozen (-80°C) subject serum was brought up to room temperature and assayed using the 185 
Invitrogen human inflammation 20-plex ProcartaPlex cytokine panel (Thermo Fisher Scientific, 186 
Waltham, MA) on a Luminex 200 instrument (Luminex, Austin, TX) in universal assay buffer. 187 
Assayed cytokines included: MIP-1α, IL-1β, IL-4, IP-10, IL-6, IL-8, IL-10, IL-12p70, IL-13, IL-188 
17A, IFN-γ, GM-CSF, TNF-α, MIP-1β, IFN-α, MCP-1, P-Selectin, IL-1α, sICAM-1, and E-189 
Selectin. Following manufacturer protocols, all samples were run on a plate with 7 standards 190 
(diluted 1:4) and a control (universal assay buffer only), with all samples, standards, and 191 
controls run in duplicate similar to our methods previously (Pessoa et al., 2019; Kleinstein et al., 192 
2020) . 193 
 194 
Quality control (QC) steps were conducted according to manufacturer recommendations by 195 
xPONENT 4.2 software (Affymetrix eBioscience, San Diego, USA). Any standards with <70 or 196 
>130 % recovery of beads were invalidated. Samples were required to have a bead count of 197 
>30 beads recovered (all samples had >100 beads recovered and none were excluded at this 198 
step). Following QC, results were reported as average pg/mL for all measured cytokines. The 199 
lower limit of quantification (LLOQ) was determined based on the standard curve (after QC) as 200 
the average value of the lowest validated standards. Values at or below the LLOQ for each 201 
cytokine were reported at the LLOQ. As samples were run in two batches (with similar LLOQs 202 
for each batch), LLOQ for the cytokines (in pg/mL) were averaged across both runs: MIP-203 
1α=1.79, IL-1β=5.58, IL-4=23.99, IP-10= 1.17, IL-6=18.89, IL-8=2.48, IL-10=2.01, IL-204 
12p70=11.72, IL-13=5.63, IL-17A=4.63, IFN-γ=11.93, GM-CSF=14.57, TNF-α=9.66, MIP-205 
1β=7.66, IFN-α=1.32, MCP-1=3.73, P-Selectin=1077.15, IL-1α=0.74, sICAM-1=442.80, and E-206 
Selectin=441.00. To compare cytokine levels between study groups, unpaired t-tests were used 207 
with a significance threshold of p<0.05 and no assumption of consistent standard deviation. 208 
 209 
Minimum Entropy Decomposition analysis of sequence libraries 210 
  211 
Poor quality reads were discarded using flexbar (Dodt et al., 2012). Reads were then treated as 212 
single end reads and trimmed for quality and to a length of 160bp using Trimmomatic (Bolger, 213 
Lohse and Usadel, 2014). Minimum Entropy Decomposition (MED) was performed as described 214 
in the oligotyping pipeline (Eren et al., 2015), generating a list of node representative sequences 215 
and their relative abundances. Taxonomic assignment of representative sequences were 216 
generated based on aligning 16s rRNA sequences at 98.5% identity against the eHOMD 217 
database (Escapa et al., 2018) and further evaluated using the Ribosomal Database Project 218 
(RDP) database (Cole et al., 2014). MED nodes were assigned species level taxonomy based 219 
on >98.5% identity matches to eHOMD and/or RDP with eHOMD designations used as 1st 220 
priority as our intial aim was to identify oral taxa. Node frequency tables now assigned 221 
taxonomy were then used in association with sample metadata for Linear Discriminate Effect 222 
Size analysis (LEfSe) (Segata et al., 2011). 223 
QIIME2 analysis of sequence libraries 224 
 225 
*All Scripts at end of this document. All work was performed on the University of Rhode Island 226 
High Performance Computing Bluewaves cluster:  227 
https://web.uri.edu/hpc-research-computing/cluster-specifications/ 228 
Data Import 229 
Fastq sequence data were imported using the import-fastq.sh script. Generated demux.qzv 230 
files were viewed using https://view.qiime2.org/ via the “quality viewer” function to determine 231 
location for sequence quality trimming used in the following step.  232 
Fastq Trimming, DADA2 Analysis, Run-run Merging 233 
A second sequencing run of the prepared Illumina libraries was performed to ensure maximum 234 
sequencing depth without further PCR amplification of starting template. At the end of the “D2-235 
merge.sh” script we then used the Rarefaction-alpha.sh script output (Fig. S2) to determine 236 
read depth (22,000) to use in downstream commands. 237 
Initial Alpha and Beta Diversity Measurements and Run-run Comparison Testing 238 
Merged libraries were used in the Alpha-Beta-An.sh script to determine initial phylogenetics on 239 
unfiltered data using the QIIME2 core-metrics-phylogenetic function, Alpha and Beta diversity 240 
calculations via QIIME2 alpha- or beta-group-significance functions as well as Beta diversity 241 
difference calculation (beta-group-significance) between sequencing Run 1 vs. Run 2 (Figs. S3, 242 
S4).   243 
Mock Community Standards Quality Control Testing 244 
This section uses the mocklibQC1.sh and mocklibQC2.sh scripts. Taxonomy files used are 245 
described below. The *-bar-plots.qzv file generated in the 1st script was viewed at 246 
https://view.qiime2.org/ and the level 6 data from this plot was exported as a .csv file which 247 
provides the reads per each taxa. This data was converted to proportion of total reads per each 248 
taxa and converted into the Zymo_actual.tsv file. The Zymo_expected.tsv file was generated by 249 
editing the Zymo_actual.tsv file with the proportion for each taxa present as provided in the 250 
manufacturers reference: 251 
https://files.zymoresearch.com/protocols/_d6305_d6306_zymobiomics_microbial_community_d252 
na_standard.pdf 253 
These .tsv inputs were then used in the mocklibQC2.sh script to output the visualizations seen 254 
in Figure S1.  255 
Classifier Setup and Editing  256 
Initial import of the SILVA 132 classifier was performed by running the following command: 257 
wget https://data.qiime2.org/2019.7/common/silva-132-99-nb-classifier.qza  258 
Classifier setup was then performed using the classifier.sh script. Upon searching the silva-259 
taxonomy.qzv file generated, we noted that there were no reads that matched A. baumanii 260 
sequences at all. We used the rep-seqs.merge.qzv file output from the D2merge.sh script 261 
saved as a FASTA file from within the QIIME2 viewer function and performed a pairwise blast vs 262 
the full length A. baumanii 16S sequence from NCBI:  263 

























CCGATGACTGGGGTGAAGT  289 
One ASV from the rep-seqs.merge.qzv file (e875355f3179838110485d8f5013d4a6) returned a 290 
100% match homology to the above A. baumanii sequence. This ASV was just annotated as 291 
Acinetobacter in the SILVA-132-99 taxonomy. We then edited the silva classifier taxonomy file 292 
by first exporting it using the following commands:  293 
module load QIIME2/2019.7 294 
qiime tools export \ 295 
 --input-path silva-taxonomy.qza \ 296 
 --output-path silva-taxonomy  297 
This output the file in *.tsv format which was then opened in a text editor and searched for the 298 
ASV node identity and then modified as indicated here:  299 
before 300 
e875355f3179838110485d8f5013d4a6    301 
D_0__Bacteria;D_1__Proteobacteria;D_2__Gammaproteobacteria;D_3__Pseudomonadales;D302 
_4__Moraxellaceae;D_5__Acinetobacter    0.9999662516375396 303 
after 304 
e875355f3179838110485d8f5013d4a6    305 
D_0__Bacteria;D_1__Proteobacteria;D_2__Gammaproteobacteria;D_3__Pseudomonadales;D306 
_4__Moraxellaceae;D_5__Acinetobacter;D_6__Acinetobacter baumanii    307 
0.9999662516375396  308 
The edited file was then saved as taxonomy-1.tsv and imported via the following command: 309 
qiime tools import \ 310 
  --input-path /data/mramseylab/classifiers/silva-taxonomy/taxonomy-1.tsv \ 311 
  --type 'FeatureData[Taxonomy]' \ 312 
  --input-format TSVTaxonomyFormat \ 313 
  --output-path silva-mod-taxonomy.qza  314 
qiime metadata tabulate \ 315 
  --m-input-file silva-mod-taxonomy.qza \ 316 
  --o-visualization silva-mod-taxonomy.qzv  317 
The silva-mod-taxonomy.qza file was used for the rest of our analyses.  318 
Data Filtering 319 
Data presented throughout the manuscript is generally described as “Minimally Filtered” or 320 
“Strict Filtered”. We 1st began with all ASV assigned data from the above scripts and used 321 
metadata based filtering to separate out all data from control samples which included no-322 
template and PCR only control indexes. This was done using the control-filter.sh script. Data 323 
output from the script was exported so it could be viewed and then used to subtract taxa from 324 
human-derived datasets in downstream filtering steps. Next we applied the meta-filter.sh script 325 
to our data to extract only human derived samples for further analysis and filtering. After this we 326 
applied the minimal-filter.sh script. Outputs from this script were used in all “Minimally Filtered” 327 
described data in the manuscript. Minimal filtering included removal of instances of taxa that 328 
appeared in only 2 samples or less, features (ASV sequences) that appeared less than 10 times 329 
across all samples and any taxa with less than 20 reads per sample.  330 
Next we took our output files from the above control-filter.sh script and used them as part of 331 
the input for the auto-filter.sh script to exclude these taxa from the remaining minimally filtered 332 
data. While this removed many spurious taxa from our samples we observed high abundance of 333 
known aquatic microbial contaminant sequences not typically human associated (ex: 334 
Sphingomonas, Ralstonia). These and other taxa were manually excluded using the strict-335 
filter.sh script and further removal of highly abundant Pseudomonas sequences were also 336 
removed via the nopa-filter.sh script. Data filtered to this extent are referred to as “Strictly” 337 
filtered in the manuscript.  338 
Re-analysis of Filtered Data 339 
A reanalysis of filtered data was performed 1st for Alpha and Beta diversity measurements via 340 
the alpha-beta2.sh script (Fig. 1). Further description and statistical analysis of Beta diversity 341 
differences were performed in R using the vegan package via the metaMDS and Adonis 342 
functions primarily as demonstrated in the MMR20_ellipses_NMDS.R script below.  343 
LEfSe Analysis Comparison 344 
Initial LEfSe analysis was performed using ASV output abundance data directly from the initial 345 
MED pipeline (Fig. 3). Further analysis on QIIME2 / DADA2 assigned strictly filtered data (Fig. 346 
S5) was performed first using the lefse-noTax.sh script to export and format data for analysis 347 
on the LEfSe Galaxy server (https://huttenhower.sph.harvard.edu/galaxy/). This script only 348 
outputs ASV node information without taxonomic assignment. Manual taxonomic assignment 349 
was performed comparing ASV node names to the rep-seqs-merge.qza file from the 350 
D2merge.sh script. LEfSe analysis was performed using default settings, *.svg output files were 351 
further edited in InkScape software for clarity.  352 
  353 
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Supplemental Data (Data S1.) Related to Transparent Methods 400 
Scripts used for analyses: 401 
 402 
import-fastq.sh 403 
module load QIIME2/2019.7 404 
 405 




qiime tools import \ 410 
  --type 'SampleData[PairedEndSequencesWithQuality]' \ 411 
  --input-path /data/mramseylab/raw_reads/2018_Serum/Run$SUFX \ 412 
  --input-format CasavaOneEightSingleLanePerSampleDirFmt \ 413 
  --output-path /data/mramseylab/raw_reads/2018_Serum/Run$SUFX/demux-414 
$SUFX.qza 415 
 416 
qiime demux summarize \ 417 
  --i-data /data/mramseylab/raw_reads/2018_Serum/Run$SUFX/demux-418 
$SUFX.qza \ 419 
  --o-visualization /data/mramseylab/visualizations/demux-$SUFX.qzv 420 
 421 
done 422 
  423 
D2merge.sh 424 
 425 
module load QIIME2/2019.7 426 
 427 




qiime dada2 denoise-single \ 432 
  --i-demultiplexed-seqs 433 
/data/mramseylab/raw_reads/2018_Serum/Run$SUFX/demux-$SUFX.qza \ 434 
  --p-trim-left 13 \ 435 
  --p-trunc-len 250 \ 436 
  --o-table /data/mramseylab/raw_reads/2018_Serum/Run$SUFX/denoise-437 
table-$SUFX.qza \ 438 
  --o-representative-sequences 439 
/data/mramseylab/raw_reads/2018_Serum/Run$SUFX/rep-seqs-$SUFX.qza \ 440 





#Have to MERGE Run1 and Run2 to get pairwise comparison 446 
#Must make directory before running below else it will error out. 447 
 448 
mkdir /data/mramseylab/raw_reads/2018_Serum/Merge_runs/ 449 
 450 
qiime feature-table merge \ 451 
  --i-tables /data/mramseylab/raw_reads/2018_Serum/Run1/denoise-table-452 
1.qza \ 453 
  --i-tables /data/mramseylab/raw_reads/2018_Serum/Run2/denoise-table-454 
2.qza \ 455 




qiime feature-table merge-seqs \ 460 
  --i-data /data/mramseylab/raw_reads/2018_Serum/Run1/rep-seqs-1.qza \ 461 
  --i-data /data/mramseylab/raw_reads/2018_Serum/Run2/rep-seqs-2.qza \ 462 
  --o-merged-data 463 
/data/mramseylab/raw_reads/2018_Serum/Merge_runs/rep-seqs-merge.qza 464 
 465 
qiime feature-table summarize \ 466 
  --i-table /data/mramseylab/raw_reads/2018_Serum/Merge_runs/denoise-467 
table-merge.qza \ 468 
  --o-visualization /data/mramseylab/visualizations/denoise-table-469 
merge.qzv \ 470 
  --m-sample-metadata-file /data/mramseylab/metadata/Serum5.tsv 471 
 472 
qiime feature-table tabulate-seqs \ 473 
  --i-data /data/mramseylab/raw_reads/2018_Serum/Merge_runs/rep-seqs-474 
merge.qza \ 475 
  --o-visualization /data/mramseylab/visualizations/rep-seqs-merge.qzv 476 
 477 
qiime phylogeny align-to-tree-mafft-fasttree \ 478 
  --i-sequences /data/mramseylab/raw_reads/2018_Serum/Merge_runs/rep-479 
seqs-merge.qza \ 480 
  --o-alignment 481 
/data/mramseylab/raw_reads/2018_Serum/Merge_runs/aligned-rep-seqs-482 
merge.qza \ 483 
  --o-masked-alignment 484 
/data/mramseylab/raw_reads/2018_Serum/Merge_runs/masked-aligned-rep-485 
seqs-merge.qza \ 486 
  --o-tree /data/mramseylab/raw_reads/2018_Serum/Merge_runs/unrooted-487 
tree-merge.qza \ 488 
  --o-rooted-tree 489 
/data/mramseylab/raw_reads/2018_Serum/Merge_runs/rooted-tree-merge.qza 490 
Rarefaction-alpha.sh 491 







qiime diversity alpha-rarefaction \ 499 
  --i-table $rawdir\denoise-table-merge.qza \ 500 
  --i-phylogeny $rawdir\rooted-tree-merge.qza \ 501 
  --p-max-depth 25000 \ 502 
  --m-metadata-file $metadir\Serum4.tsv \ 503 






  510 
Alpha-Beta-An.sh 511 







qiime diversity core-metrics-phylogenetic \ 519 
  --i-phylogeny $rawdir\rooted-tree-merge.qza \ 520 
  --i-table  $rawdir\denoise-table-merge.qza \ 521 
  --p-sampling-depth 22000 \ 522 
  --m-metadata-file $metadir\Serum5.tsv \ 523 
  --output-dir $procdir$cmr\-initial 524 
 525 
qiime diversity alpha-group-significance \ 526 
  --i-alpha-diversity $procdir$cmr\-initial/faith_pd_vector.qza \ 527 
  --m-metadata-file $metadir\Serum5.tsv \ 528 
  --o-visualization $procdir$cmr\-initial/faith-pd-group-529 
significance.qzv 530 
 531 
qiime diversity alpha-group-significance \ 532 
  --i-alpha-diversity $procdir$cmr\-initial/evenness_vector.qza \ 533 
  --m-metadata-file $metadir\Serum5.tsv \ 534 
  --o-visualization $procdir$cmr\-initial/evenness-group-535 
significance.qzv 536 
 537 
array=( unweighted_unifrac_distance_matrix 538 
weighted_unifrac_distance_matrix bray_curtis_distance_matrix ) 539 
 540 
for i in "${array[@]}" 541 
do 542 
 543 
qiime diversity beta-group-significance \ 544 
  --i-distance-matrix $procdir$cmr\-initial/$i.qza \ 545 
  --m-metadata-file  $metadir\Serum5.tsv \ 546 
  --m-metadata-column Condition \ 547 
  --o-visualization $procdir$cmr\-initial/$i.qzv \ 548 




#Generates data for run1 vs run2 variability to measure batch effect 553 
qiime diversity beta-group-significance \ 554 
  --i-distance-matrix $procdir$cmr\-555 
initial/unweighted_unifrac_distance_matrix.qza \ 556 
  --m-metadata-file $metadir\Serum4.tsv \ 557 
  --m-metadata-column Run \ 558 
  --o-visualization $procdir$cmr\-initial/unweighted-unifrac-Run-559 
significance.qzv \ 560 
  --p-pairwise 561 
  562 
Classifier.sh 563 





#for the silva release 132 99 .fna file 569 
 570 
qiime feature-classifier classify-sklearn \ 571 
  --i-classifier $clsdir\silva-132-99-nb-classifier.qza \ 572 
  --i-reads $rawdir\rep-seqs-merge.qza \ 573 
  --o-classification $clsdir\silva-taxonomy.qza 574 
 575 
#output the taxonomy table to check for A. baumanii strains in it 576 
afterwards.  577 
 578 
qiime metadata tabulate \ 579 
  --m-input-file $clsdir\silva-taxonomy.qza \ 580 
  --o-visualization $clsdir\silva-taxonomy.qzv 581 
  582 
Control-filter.sh 583 








# filter status of input files, "ctrl-filter" is just for taxa 592 




#must make the directory you are filtering to 1st or else it will 597 
error 598 
mkdir $filtdir$fil 599 
 600 
 601 
qiime feature-table filter-samples \ 602 
  --i-table $tablein \ 603 
  --m-metadata-file $metadir\Serum5.tsv \ 604 
  --p-where "[Source]='Control'" \ 605 
  --o-filtered-table $filtdir$fil/$fil-table.qza 606 
 607 
qiime taxa collapse \ 608 
  --i-table $filtdir$fil/$fil-table.qza \ 609 
  --i-taxonomy $clsdir\silva-mod-taxonomy.qza \ 610 
  --p-level 6 \ 611 
  --o-collapsed-table $filtdir$fil/$fil-collapse-table.qza 612 
 613 
qiime feature-table relative-frequency \ 614 
  --i-table $filtdir$fil/$fil-collapse-table.qza \ 615 
  --o-relative-frequency-table $filtdir$fil/$fil-relative-collapse-616 
table.qza 617 
 618 
qiime tools export \ 619 
  --input-path $filtdir$fil/$fil-relative-collapse-table.qza \ 620 
  --output-path $filtdir$fil/ 621 
 622 
biom convert \ 623 
-i $filtdir$fil/feature-table.biom \ 624 
-o $filtdir$fil/$fil-relative-collapse-table.txt \ 625 
--header-key “taxonomy” \ 626 
--to-tsv 627 
 628 
#Use above taxa table to filter out based on taxa present in controls 629 
 630 
qiime feature-table filter-features \ 631 
  --i-table $tablein \ 632 
  --m-metadata-file $filtdir$fil/$fil-collapse-table.qza \ 633 
  --o-filtered-table $filtdir$fil/$fil-excluded-table.qza \ 634 
  --p-exclude-ids 635 
 636 
#Use excluded table to generate barplot for checking 637 
 638 
qiime taxa barplot \ 639 
  --i-table $filtdir$fil/$fil-excluded-table.qza \ 640 
  --i-taxonomy $clsdir\silva-mod-taxonomy.qza \ 641 
  --m-metadata-file $metadir\Serum5.tsv \ 642 
  --o-visualization $filtdir$fil/$fil-excluded-table.qzv 643 
  644 
Meta-filter.sh 645 








# filter status of input files, "initial" is the 1st pass no filter at 654 
all 655 
# "initial-human" is the initial data but for only human samples, no 656 
mock or control samples 657 
fil=initial-human   658 
 659 
#note must make directores needed BEFORE running the below command 660 
mkdir $filtdir$fil 661 
 662 
qiime feature-table filter-samples \ 663 
  --i-table $tablein \ 664 
  --m-metadata-file $metadir\Serum5.tsv \ 665 
  --p-where "[Source]='Human'" \ 666 
  --o-filtered-table $filtdir$fil/$fil-table.qza 667 
  668 
Auto-filter.sh 669 








# filter status of input files, "ctrl-filter" is just for taxa 678 
belonging to no template controls 679 
fil=AF-hum 680 
#must make the directory you are filtering to 1st or else it will 681 
error 682 
mkdir $filtdir$fil 683 
 684 
#Filtering list from mock samples was generated previously with the 685 
control-filter.sh script 686 
 687 
qiime feature-table filter-features \ 688 
  --i-table $tablein \ 689 
  --m-metadata-file /data/mramseylab/proc_reads/ctrl-filter/ctrl-690 
filter-collapse-table.qza \ 691 
  --o-filtered-table $filtdir$fil/$fil-excluded-table.qza \ 692 
  --p-exclude-ids 693 
 694 
#Use excluded table to generate barplot for checking 695 
qiime taxa barplot \ 696 
  --i-table $filtdir$fil/$fil-excluded-table.qza \ 697 
  --i-taxonomy $clsdir\silva-mod-taxonomy2.qza \ 698 
  --m-metadata-file $metadir\Serum5.tsv \ 699 
  --o-visualization $filtdir$fil/$fil-excluded-table.qzv 700 
 701 
#Generate viewable feature table to look for ASVs of interest / 702 
filtering stats 703 
qiime feature-table summarize \ 704 
  --i-table $filtdir$fil/$fil-excluded-table.qza \ 705 
  --o-visualization $filtdir$fil/$fil-excluded-table2.qzv \ 706 
  --m-sample-metadata-file $metadir\Serum5.tsv 707 
  708 
Strict-filter.sh 709 








# filter status of input files, "ctrl-filter" is just for taxa 718 
belonging to no template controls 719 
fil=SF-hum 720 
#must make the directory you are filtering to 1st or else it will 721 
error 722 
mkdir $filtdir$fil 723 
 724 
#Filtering list from mock samples was generated previously with the 725 
auto-filter.sh script 726 
 727 
#Tidying up name here so I can repeatedly use the same input below 728 
through the loop 729 
cp $tablein.qza /$filtdir$fil/$fil-table.qza 730 
#Array here contains all taxa I wish to remove 731 
array=( Chloroplast Mitochondria Ralstonia Chryseobacterium 732 
Sphingomonas Enhydrobacter Bradyrhizobium Sphingomonadales Rhizobiales 733 
Rhodobacterales Sphingobacteriales Halomonadaceae Deinococcales ) 734 
 735 
for i in "${array[@]}" 736 
do 737 
 738 
qiime taxa filter-table \ 739 
  --i-table /$filtdir$fil/$fil-table.qza \ 740 
  --i-taxonomy $clsdir\silva-mod-taxonomy2.qza \ 741 
  --p-mode contains \ 742 
  --p-exclude "$i" \ 743 
  --o-filtered-table /$filtdir$fil/$fil-table.qza 744 
 745 
done 746 
#Use excluded table to generate barplot for checking 747 
qiime taxa barplot \ 748 
  --i-table /$filtdir$fil/$fil-table.qza \ 749 
  --i-taxonomy $clsdir\silva-mod-taxonomy2.qza \ 750 
  --m-metadata-file $metadir\Serum5.tsv \ 751 
  --o-visualization /$filtdir$fil/$fil-table-barplot.qzv 752 
 753 
#Generate viewable feature table to look for ASVs of interest / 754 
filtering stats 755 
qiime feature-table summarize \ 756 
  --i-table /$filtdir$fil/$fil-table.qza \ 757 
  --o-visualization /$filtdir$fil/$fil-table.qzv \ 758 
  --m-sample-metadata-file $metadir\Serum5.tsv 759 
  760 
Nopa-filter.sh 761 








# filter status of input files, "ctrl-filter" is just for taxa 770 
belonging to no template controls 771 
fil=NP-hum 772 
#must make the directory you are filtering to 1st or else it will 773 
error 774 
mkdir $filtdir$fil 775 
 776 
#Filtering list from mock samples was generated previously with the 777 
strict-filter.sh script 778 
 779 
qiime taxa filter-table \ 780 
  --i-table $tablein \ 781 
  --i-taxonomy $clsdir\silva-mod-taxonomy2.qza \ 782 
  --p-mode contains \ 783 
  --p-exclude "Pseudomonas" \ 784 
  --o-filtered-table $filtdir$fil/$fil-table.qza 785 
 786 
#Use excluded table to generate barplot for checking 787 
qiime taxa barplot \ 788 
  --i-table $filtdir$fil/$fil-table.qza \ 789 
  --i-taxonomy $clsdir\silva-mod-taxonomy2.qza \ 790 
  --m-metadata-file $metadir\Serum5.tsv \ 791 
  --o-visualization $filtdir$fil/$fil-table-barplot.qzv 792 
 793 
#Generate viewable feature table to look for ASVs of interest / 794 
filtering stats 795 
qiime feature-table summarize \ 796 
  --i-table $filtdir$fil/$fil-table.qza \ 797 
  --o-visualization $filtdir$fil/$fil-table.qzv \ 798 
  --m-sample-metadata-file $metadir\Serum5.tsv 799 
  800 
Alpha-beta2.sh 801 











#note change name of input tables for the 1st command below. Some 813 
input tables did not have standardized filename conventions 814 
#changed to AF-hum-table.qza and table3.qza to minF-hum-table.qza 815 
 816 
array=( minF AF SF NP ) 817 
 818 
for i in "${array[@]}" 819 
do 820 
 821 
qiime diversity core-metrics-phylogenetic \ 822 
  --i-phylogeny $rawdir\rooted-tree-merge.qza \ 823 
  --i-table  $procdir$i\-hum/$i\-hum-table.qza \ 824 
  --p-sampling-depth 5000 \ 825 
  --m-metadata-file $metadir\Serum5.tsv \ 826 
  --output-dir $procdir$i\-hum/$cmr 827 
 828 
qiime diversity alpha-group-significance \ 829 
  --i-alpha-diversity $procdir$i\-hum/$cmr/faith_pd_vector.qza \ 830 
  --m-metadata-file $metadir\Serum5.tsv \ 831 
  --o-visualization $procdir$i\-hum/$cmr/faith-pd-group-832 
significance.qzv 833 
 834 
qiime diversity alpha-group-significance \ 835 
  --i-alpha-diversity $procdir$i\-hum/$cmr/evenness_vector.qza \ 836 
  --m-metadata-file $metadir\Serum5.tsv \ 837 





#dual array taking the directories above and then running the next 843 
command on the 3 filenames in array2 for each directory prefix in 844 
array 1 845 
#note different array command syntax from above vs below 846 
 847 
array1=( minF AF SF NP )  848 
array2=( unweighted_unifrac_distance_matrix 849 
weighted_unifrac_distance_matrix bray_curtis_distance_matrix )  850 
for indirs in ${array1[@]}  851 
do 852 
    for infils in ${array2[@]} 853 
    do  854 
 855 
qiime diversity beta-group-significance \ 856 
  --i-distance-matrix $procdir$indirs\-hum/$cmr/$infils\.qza \ 857 
  --m-metadata-file $metadir\Serum5.tsv \ 858 
  --m-metadata-column Condition \ 859 
  --o-visualization $procdir$indirs\-hum/$cmr/$infils\.qzv \ 860 
  --p-pairwise 861 
    done  862 
done 863 
  864 
MMR20_ellipses_NMDS.R 865 






metadata<-read.csv("Serum5.tsv", header=TRUE, sep="\t", 872 
stringsAsFactors = F) 873 
featuredf<-read.csv("NP-hum-features.tsv", header=TRUE, sep="\t", 874 
stringsAsFactors = F) 875 
 876 
#making a subset of human only metadata and a few other criteria. 877 
metadata <- metadata %>% filter(Source == 'Human') %>% 878 
select("sample.id","Condition","Run","Source","ABC") 879 
 880 
#Fixing 1st row to make it row names 881 
featuredf <- data.frame(featuredf[,-1], row.names = featuredf[,1]) 882 
 883 
#transposing trial1 table to match Evelyns data format 884 
featuredf <- as.data.frame(t(featuredf)) 885 
 886 
#Brings tables into agreement on matching sample.id values 887 
featuredf = featuredf %>% mutate(sample.id = rownames(featuredf)) 888 
 889 
#Brings tables into agreement on matching sample.id values 890 
table_all = left_join(featuredf, metadata) 891 
 892 
#This gets metadata to agree with row numbers of the features table 893 
after splitting out from table_all 894 
metadata <- 895 
select(table_all,"sample.id","Condition","Run","Source","ABC") 896 
 897 
#filter the "sample.id" column off the very end of the dataframe and 898 
turn it into rownames 899 
#NOTE THIS VALUE MUST BE CHANGED FOR EACH INPUT 900 
featuredf <- data.frame(featuredf[,-1101], row.names = 901 
featuredf[,1101]) 902 
 903 
# normalize data by sum of ASVs in each sample (this was from ZP's 904 
code) 905 
featuredf <- sweep(featuredf,2,colSums(featuredf),`/`) 906 
 907 
##Above this was all data input / manipulation, Below this is data 908 
analysis and plotting## 909 
 910 
### The function metaMDS is used to calculate the dissimilarity matrix 911 
using the bray curtis distance metrics and at the same 912 
#time generates the values from the dissimilarity matrix for  an 913 
ordination plot. 914 
MDS <-metaMDS(featuredf ,distance = "bray", k = 3, trymax = 500) 915 
 916 
## Next, extract the x and y coordinates from the MDS plot into a new 917 
data frame and add the metadata factors to the coordinates the data 918 
should be plotted based on. 919 
#MMR- added ABC=as.factor and changed [,3] to [,5] to agree with my 920 
own metadata file. 921 
NMDS_t1=data.frame(NMDS1=MDS$point[,1],NMDS2=MDS$point[,2], 922 
                   Condition=table_all$Condition,ABC=table_all$ABC) 923 
 924 
## set theme for following plots 925 
theme_set(theme_bw()) 926 
 927 
## Generate the ordination based on the solution from above and 928 
selected grouping factor (Condition) 929 
plot.new() 930 
ord<-ordiellipse(MDS, table_all$Condition, 931 
                    display = "sites", kind ="sd", conf = 0.95, label 932 
= T) 933 
dev.off() 934 
 935 
## Data frame df_ell_t1 contains values to show ellipses. It is 936 
calculated with function veganCovEllipse which is hidden in vegan 937 
package. 938 
#This function is applied to each level of NMDS (group) and it uses 939 
also function cov.wt to calculate covariance matrix. 940 
veganCovEllipse<-function (cov, center = c(0, 0), scale = 1, npoints = 941 
100) 942 
{ 943 
  theta <- (0:npoints) * 2 * pi/npoints 944 
  Circle <- cbind(cos(theta), sin(theta)) 945 
  t(center + scale * t(Circle %*% chol(cov))) 946 
} 947 
 948 
##Generate ellipse points based on 95% confidence (SD) intervals 949 
#Reference : http://stackoverflow.com/questions/13794419/plotting-950 
ordiellipse-function-from-vegan-package-onto-nmds-plot-created-in-951 
ggplot 952 
#Data frame df_ell contains values to show ellipses. It is calculated 953 
with function veganCovEllipse which is hidden in vegan package. This 954 
function is applied to each level of NMDS (group) and it uses also 955 
function cov.wt to calculate covariance matrix. 956 
df_ell_t1 <- data.frame() 957 
for(g in levels(NMDS_t1$Condition)){ 958 
  if(g!="" && (g %in% names(ord))){ 959 
    df_ell_t1 <- rbind(df_ell_t1, 960 
cbind(as.data.frame(with(NMDS_t1[NMDS_t1$Condition==g,], 961 




## Calculate p-value: 966 
adon_t1<-adonis2(featuredf ~Condition, data=metadata, 967 
by=NULL,method="bray", k=3) 968 
 969 
NMDSplot_t1<-ggplot(data=NMDS_t1,aes(NMDS1,NMDS2,col=Condition))+ 970 
    #update from Evelyn to add metadata text to plot if wanted 971 
  #This is useful to identify outlier points if using sample ID text 972 
here, Remove for final plot 973 
###  974 
geom_text(aes(NMDS1,NMDS2,label=table_all$sample.id),size=2,vjust=0)+ 975 
  # add the p-value in the bottom right corner 976 
  annotate("text",x=min(NMDS_t1$NMDS1),y=min(NMDS_t1$NMDS2-0.5), 977 
           label=paste("p= ", adon_t1$`Pr(>F)`[1]),size=3)+ 978 
  # draw the ellipses and define color based on the grouping factor 979 
  geom_path(data=df_ell_t1, aes(x=NMDS1, y=NMDS2, linetype=Condition), 980 
size=1)+ 981 
  #scale_linetype_manual(values=c("4-Con"="dotted","3-S4"="solid","2-982 
RI-old"="longdash"))+ 983 
  #scale_colour_manual(values=c("4-Con"="red", "3-S4"="darkgreen", "2-984 
RI-old"="purple"))+ 985 
  # add the points per sample and define shape based on TankLocation 986 
  geom_point(aes(shape=ABC), size=2) + 987 
  # Reorder the legend 988 
  guides(color = guide_legend(order=1),lty= guide_legend(order=1), 989 
         shape = guide_legend(order=2), legend.position = "bottom") 990 
 991 
# Adding other Aethestics 992 
NMDS_by_Trial1 <- NMDSplot_t1 + theme(axis.text.y = 993 
element_text(size="12", color="black"), axis.title.y = 994 
element_text(face="bold",size="12", color="black"))+ 995 
  theme(axis.text.x = element_text(size="12", color="black"), 996 
axis.title.x.bottom = element_text(face="bold",size="12", 997 
color="black"))+ 998 
  theme(axis.text.x.top= element_text(face="bold",size="12", 999 
color="black")) + 1000 
  #change name of the legend 1001 
  theme(legend.title=element_blank())+ 1002 
  theme(legend.position = "right", legend.title = 1003 





  1009 
Lefse-noTax.sh 1010 









array=( minF-hum AF-hum SF-hum NP-hum ) 1020 
 1021 
for i in "${array[@]}" 1022 
do 1023 
 1024 
qiime feature-table relative-frequency \ 1025 
 --i-table $filtdir$i/$i\-table.qza \ 1026 
 --o-relative-frequency-table $filtdir$i/$i\-table.notax.qza 1027 
 1028 
qiime tools export \ 1029 
 --input-path $filtdir$i/$i\-table.notax.qza \ 1030 
 --output-path $filtdir$i/ 1031 
 1032 
#note, must use single hashes for -i / -o unlike other qiime commands. 1033 
biom convert \ 1034 
 -i $filtdir$i/feature-table.biom \ 1035 
 -o $filtdir$i/$i\-notax.table.txt \ 1036 
 --header-key “taxonomy” \ 1037 
 --to-tsv 1038 
 1039 
done 1040 
 1041 
 1042 
